Stonepine Capital Management, LLC 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Stonepine Capital Management, LLC disclosed 52 US equity positions worth $123.9m in its Q4 2024 13F filing. The largest position was ADMA at 17.2% of the reported book, followed by EOLS and TELA. Against the Q3 2024 filing, it opened 21 new positions, added to 13 and reduced 15 among the top 50 holdings.
What did Stonepine Capital Management, LLC own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | ADMA ADMA BIOLOGICS INC | Healthcare | 17.2% | $21.3m | 1,241,032 | -34% | reduced |
| 2 | EOLS EVOLUS INC | Healthcare | 11.3% | $14.0m | 1,264,651 | -8% | reduced |
| 3 | TELA TELA BIO INC | 5.7% | $7.1m | 2,353,099 | 112% | added | |
| 4 | LKFT GALAPAGOS NV-SPON ADR | Healthcare | 4.4% | $5.5m | 200,000 | -58% | reduced |
| 5 | ZVRA ZEVRA THERAPEUTICS INC | 4.0% | $5.0m | 597,700 | -15% | reduced | |
| 6 | VSTM VERASTEM INC | Healthcare | 3.6% | $4.5m | 870,000 | -34% | reduced |
| 7 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 3.3% | $4.0m | 220,000 | 12% | added |
| 8 | OPTNUSD OPTINOSE INC | 3.2% | $3.9m | 588,657 | – | new | |
| 9 | ANIK ANIKA THERAPEUTICS INC | Healthcare | 3.2% | $3.9m | 238,222 | 26% | added |
| 10 | INDIVIOR PLC | 3.1% | $3.8m | 305,000 | 13% | added | |
| 11 | ESTA ESTABLISHMENT LABS HOLDINGS | Healthcare | 3.0% | $3.7m | 80,002 | 7% | added |
| 12 | IKT INHIBIKASE THERAPEUTICS INC | 3.0% | $3.7m | 1,132,388 | – | new | |
| 13 | URGN UROGEN PHARMA LTD | Healthcare | 2.8% | $3.5m | 324,324 | 16% | added |
| 14 | XOMA CORP | 2.7% | $3.3m | 125,700 | -36% | reduced | |
| 15 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 2.4% | $3.0m | 235,000 | 14% | added | |
| 16 | IRWD IRONWOOD PHARMACEUTICALS INC | Healthcare | 2.3% | $2.9m | 648,785 | -35% | reduced |
| 17 | SCPH SCPHARMACEUTICALS INC | 2.0% | $2.4m | 683,530 | -12% | reduced | |
| 18 | SRZN SURROZEN INC | 1.6% | $2.0m | 137,200 | 25% | added | |
| 19 | INO INOVIO PHARMACEUTICALS INC | 1.6% | $1.9m | 1,050,000 | – | new | |
| 20 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 1.5% | $1.9m | 331,900 | – | new |
| 21 | MYO MYOMO INC | 1.4% | $1.8m | 274,426 | 174% | added | |
| 22 | CALC CALCIMEDICA INC | 1.3% | $1.7m | 468,793 | – | new | |
| 23 | ACRS ACLARIS THERAPEUTICS INC | Healthcare | 1.3% | $1.6m | 663,405 | -73% | reduced |
| 24 | PROF PROFOUND MEDICAL CORP | 1.2% | $1.5m | 200,000 | – | new | |
| 25 | JAZZ JAZZ PHARMACEUTICALS PLC US LISTED | Healthcare | 1.0% | $1.2m | 10,000 | -82% | reduced |
| 26 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 1.0% | $1.2m | 164,106 | – | new |
| 27 | MIST MILESTONE PHARMACEUTICALS IN | 1.0% | $1.2m | 500,000 | -50% | reduced | |
| 28 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 0.9% | $1.1m | 20,400 | – | new |
| 29 | HRTX HERON THERAPEUTICS INC | Healthcare | 0.9% | $1.1m | 700,000 | – | new |
| 30 | XGN EXAGEN INC | 0.8% | $1.0m | 251,049 | -53% | reduced | |
| 31 | TSVT* 2SEVENTY BIO INC | 0.7% | $882.0k | 300,000 | 200% | added | |
| 32 | 2662247D ITEOS THERAPEUTICS INC | 0.7% | $844.8k | 110,000 | 267% | added | |
| 33 | PMVP PMV PHARMACEUTICALS INC | 0.7% | $809.1k | 535,805 | – | new | |
| 34 | 2KZ0 KEZAR LIFE SCIENCES INC | 0.6% | $739.2k | 110,000 | – | new | |
| 35 | AYTU AYTU BIOPHARMA INC | 0.6% | $692.8k | 407,549 | -19% | reduced | |
| 36 | ACET ADICET BIO INC | Healthcare | 0.5% | $673.4k | 700,000 | 15% | added |
| 37 | KPRX KIORA PHARMACEUTICALS INC | 0.5% | $663.2k | 200,970 | -1% | reduced | |
| 38 | XERS XERIS BIOPHARMA HOLDINGS INC | Healthcare | 0.5% | $618.1k | 182,317 | – | new |
| 39 | AQST AQUESTIVE THERAPEUTICS INC | 0.5% | $569.6k | 160,000 | – | new | |
| 40 | APRE APREA THERAPEUTICS INC | 0.4% | $490.9k | 149,221 | 9% | added | |
| 41 | ACELYRIN INC | 0.3% | $417.2k | 132,870 | – | new | |
| 42 | CHRS COHERUS BIOSCIENCES INC | Healthcare | 0.3% | $345.0k | 250,000 | – | new |
| 43 | PYPD POLYPID LTD | 0.3% | $315.2k | 103,668 | -25% | reduced | |
| 44 | HILLEVAX INC | 0.2% | $274.0k | 132,347 | – | new | |
| 45 | ANTX AN2 THERAPEUTICS INC | 0.2% | $271.5k | 196,732 | – | new | |
| 46 | VNDA VANDA PHARMACEUTICALS INC | Healthcare | 0.1% | $119.8k | 25,000 | – | new |
| 47 | ELEVATION ONCOLOGY INC | 0.1% | $112.5k | 200,000 | – | new | |
| 48 | ABVX ABIVAX SA | 0.1% | $109.8k | 15,000 | – | new | |
| 49 | ALIMERA SCIENCES INC CVR | 0.1% | $107.1k | 2,408,469 | 0% | held | |
| 50 | ALLR ALLARITY THERAPEUTICS INC | 0.1% | $78.7k | 67,289 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.